{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:10:24Z","timestamp":1779351024358,"version":"3.51.4"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Cardiogenic shock is a condition that is characterized by end-organ hypoperfusion secondary to reduced cardiac output, and is associated with substantial mortality. The mainstay of therapy for cardiogenic shock is reversal of the underlying cause, and concomitant supportive care with vasoactive medications (vasopressors and inotropes). Patients who continue to deteriorate despite these measures may require mechanical circulatory support (MCS). Here, we review the devices available for MCS, and their associated benefits and risks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Despite growing use worldwide, there is little randomized evidence supporting the routine use of any specific device for MCS in cardiogenic shock. A large randomized trial of the intra-aortic balloon pump did not demonstrate short- or long-term improvement in mortality. The TandemHeart and Impella devices which assist in left ventricular unloading have only been evaluated in small randomized trials, which showed an increase in adverse events without improvement in mortality. Finally, venoarterial extracorporeal membrane oxygenation (provides both circulatory and respiratory support) and is currently being evaluated in large randomized clinical trials.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Various devices for MCS in cardiogenic shock are available, but routine use is not supported by high-quality randomized evidence. Given the resources required for initiation of MCS, use of these treatments should be limited to centers experienced in advanced cardiac care, and future research should focus on what role (if any) these devices have in clinical practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000956","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T04:00:58Z","timestamp":1657080058000},"page":"434-441","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Mechanical circulatory support in the treatment of cardiogenic shock"],"prefix":"10.1097","volume":"28","author":[{"given":"Shannon M.","family":"Fernando","sequence":"first","affiliation":[{"name":"Division of Critical Care, Department of Medicine, University of Ottawa"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa"},{"name":"Department of Critical Care, Lakeridge Health Corporation, Oshawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Price","sequence":"additional","affiliation":[{"name":"Adult Intensive Care Unit, Royal Brompton Hospital"},{"name":"National Heart and Lung Institute, Imperial College, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Mathew","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur S.","family":"Slutsky","sequence":"additional","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine, University of Toronto"},{"name":"Keenan Centre for Biomedical Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Combes","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Institute of Cardiometabolism and Nutrition"},{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re, Assistance Publique-H\u00f4pitaux de Paris, Institut de Cardiologie, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Brodie","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons"},{"name":"Center for Acute Respiratory Failure, New York-Presbyterian Hospital, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update","volume":"40","author":"Thiele","year":"2019","journal-title":"Eur Heart J"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"e005618","DOI":"10.1161\/CIRCOUTCOMES.119.005618","article-title":"Epidemiology of shock in contemporary cardiac intensive care units","volume":"12","author":"Berg","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"R5-20250729","first-page":"29","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021","volume":"79","author":"Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","article-title":"Cardiogenic shock classification to predict mortality in the cardiac intensive care unit","volume":"74","author":"Jentzer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJM199904153401504","article-title":"Temporal trends in cardiogenic shock complicating acute myocardial infarction","volume":"340","author":"Goldberg","year":"1999","journal-title":"N Engl J Med"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7326\/0003-4819-149-9-200811040-00005","article-title":"Ten-year trends in the incidence and treatment of cardiogenic shock","volume":"149","author":"Jeger","year":"2008","journal-title":"Ann Intern Med"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ejhf.1750","article-title":"Trends in cardiogenic shock complicating acute myocardial infarction","volume":"22","author":"Aissaoui","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.25011\/cim.v42i2.32813","article-title":"Efficacy of milrinone and dobutamine in low cardiac output states: systematic review and meta-analysis","volume":"42","author":"Mathew","year":"2019","journal-title":"Clin Investig Med"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew","year":"2021","journal-title":"N Engl J Med"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00134-014-3604-1","article-title":"Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis","volume":"41","author":"Koster","year":"2015","journal-title":"Intensive Care Med"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0140-6736(20)31047-3","article-title":"Temporary circulatory support for cardiogenic shock","volume":"396","author":"Combes","year":"2020","journal-title":"Lancet"},{"key":"R19-20250729","first-page":"52","article-title":"Experts\u2019 recommendations for the management of adult patients with cardiogenic shock","volume":"5","author":"Levy","year":"2015","journal-title":"Ann Intensive Care"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/CIR.0b013e3182769a54","article-title":"Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association","volume":"126","author":"Peura","year":"2012","journal-title":"Circulation"},{"key":"R21-20250729","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.05.031","article-title":"A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock","volume":"152","author":"Burkhoff","year":"2006","journal-title":"Am Heart J"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/eurheartj\/ehx363","article-title":"Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials","volume":"38","author":"Thiele","year":"2017","journal-title":"Eur Heart J"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1007\/s00134-016-4536-8","article-title":"Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis","volume":"42","author":"Ouweneel","year":"2016","journal-title":"Intensive Care Med"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00134-018-5064-5","article-title":"Position paper for the organization of ECMO programs for cardiac failure in adults","volume":"44","author":"Abrams","year":"2018","journal-title":"Intensive Care Med"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.119.040654","article-title":"Shock team approach in refractory cardiogenic shock requiring short-term mechanical circulatory support: a proof of concept","volume":"140","author":"Taleb","year":"2019","journal-title":"Circulation"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jacc.2018.12.084","article-title":"Standardized team-based care for cardiogenic shock","volume":"73","author":"Tehrani","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0002-8703(62)90012-1","article-title":"Diastolic balloon pumping (with carbon dioxide) in the aorta--a mechanical assistance to the failing circulation","volume":"63","author":"Moulopoulos","year":"1962","journal-title":"Am Heart J"},{"key":"R29-20250729","first-page":"Cd007398","article-title":"Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock","volume":"2015","author":"Unverzagt","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"e000590","DOI":"10.1161\/JAHA.113.000590","article-title":"Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States","volume":"3","author":"Kolte","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","article-title":"Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12\u200amonth results of a randomised, open-label trial","volume":"382","author":"Thiele","year":"2013","journal-title":"Lancet"},{"key":"R33-20250729","article-title":"Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II Trial","author":"Thiele","year":"2018","journal-title":"Circulation"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00392-015-0819-2","article-title":"Economic implications of intra-aortic balloon support for myocardial infarction with cardiogenic shock: an analysis from the IABP-SHOCK II-trial","volume":"104","author":"Schuster","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jacc.2010.08.613","article-title":"The percutaneous ventricular assist device in severe refractory cardiogenic shock","volume":"57","author":"Kar","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/eurheartj\/ehi161","article-title":"Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock","volume":"26","author":"Thiele","year":"2005","journal-title":"Eur Heart J"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/17434440.2018.1456334","article-title":"Overview of Impella and mechanical devices in cardiogenic shock","volume":"15","author":"Chera","year":"2018","journal-title":"Expert Rev Med Dev"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.119.044007","article-title":"The evolving landscape of impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support","volume":"141","author":"Amin","year":"2020","journal-title":"Circulation"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1007\/s12630-020-01755-9","article-title":"Long-term mortality and costs following use of Impella\u00ae for mechanical circulatory support: a population-based cohort study","volume":"67","author":"Fernando","year":"2020","journal-title":"Can J Anaesth"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.118.036614","article-title":"Impella support for acute myocardial infarction complicated by cardiogenic shock","volume":"139","author":"Schrage","year":"2019","journal-title":"Circulation"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.2020.0254","article-title":"Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock","volume":"323","author":"Dhruva","year":"2020","journal-title":"JAMA"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R45-20250729","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ahj.2019.04.019","article-title":"Rationale and design of DanGer shock: Danish-German cardiogenic shock trial","volume":"214","author":"Udesen","year":"2019","journal-title":"Am Heart J"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/CCM.0b013e31816f7cf7","article-title":"Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock","volume":"36","author":"Combes","year":"2008","journal-title":"Crit Care Med"},{"key":"R47-20250729","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s00134-018-5442-z","article-title":"Percutaneous versus surgical femoro-femoral veno-arterial ECMO: a propensity score matched study","volume":"44","author":"Danial","year":"2018","journal-title":"Intensive Care Med"},{"key":"R48-20250729","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2019.9302","article-title":"Extracorporeal life support for adults with respiratory failure and related indications: a review","volume":"322","author":"Brodie","year":"2019","journal-title":"JAMA"},{"key":"R49-20250729","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00134-016-4273-z","article-title":"Extracorporeal membrane oxygenation: evolving epidemiology and mortality","volume":"42","author":"Karagiannidis","year":"2016","journal-title":"Intensive Care Med"},{"key":"R50-20250729","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MAT.0000000000000475","article-title":"Extracorporeal life support organization registry international report","volume":"63","author":"Thiagarajan","year":"2017","journal-title":"Asaio j"},{"key":"R51-20250729","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s00134-019-05766-z","article-title":"Mortality and costs following extracorporeal membrane oxygenation in critically ill adults: a population-based cohort study","volume":"45","author":"Fernando","year":"2019","journal-title":"Intensive Care Med"},{"key":"R52-20250729","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s00134-011-2358-2","article-title":"Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock","volume":"37","author":"Aissaoui","year":"2011","journal-title":"Intensive Care Med"},{"key":"R53-20250729","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1093\/eurheartj\/ehv194","article-title":"Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score","volume":"36","author":"Schmidt","year":"2015","journal-title":"Eur Heart J"},{"key":"R54-20250729","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13054-016-1520-1","article-title":"The modified SAVE score: predicting survival using urgent veno-arterial extracorporeal membrane oxygenation within 24 h of arrival at the emergency department","volume":"20","author":"Chen","year":"2016","journal-title":"Crit Care"},{"key":"R55-20250729","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00134-016-4223-9","article-title":"The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock","volume":"42","author":"Muller","year":"2016","journal-title":"Intensive Care Med"},{"key":"R56-20250729","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1097\/CCM.0b013e3181e8acf7","article-title":"Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock","volume":"38","author":"Sheu","year":"2010","journal-title":"Crit Care Med"},{"key":"R57-20250729","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2019.02.044","article-title":"Extracorporeal life support in cardiogenic shock complicating acute myocardial infarction","volume":"73","author":"Brunner","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R58-20250729","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jacc.2018.10.085","article-title":"Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock","volume":"73","author":"Russo","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R59-20250729","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.athoracsur.2013.09.008","article-title":"Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients","volume":"97","author":"Cheng","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"R60-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00134-021-06514-y","article-title":"Extracorporeal cardiopulmonary resuscitation in adults: evidence and implications","volume":"48","author":"Abrams","year":"2022","journal-title":"Intensive Care Med"},{"key":"R61-20250729","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCULATIONAHA.119.042173","article-title":"Improved survival with extracorporeal cardiopulmonary resuscitation despite progressive metabolic derangement associated with prolonged resuscitation","volume":"141","author":"Bartos","year":"2020","journal-title":"Circulation"},{"key":"R62-20250729","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(20)32338-2","article-title":"Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial","volume":"396","author":"Yannopoulos","year":"2020","journal-title":"Lancet"},{"key":"R63-20250729","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S2213-2600(17)30263-1","article-title":"Treatment limitations in the era of ECMO","volume":"5","author":"Brodie","year":"2017","journal-title":"Lancet Respir Med"},{"key":"R64-20250729","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1378\/chest.13-1138","article-title":"Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults","volume":"145","author":"Abrams","year":"2014","journal-title":"Chest"},{"key":"R65-20250729","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s00134-017-4781-5","article-title":"Understanding ethical decisions for patients on extracorporeal life support","volume":"43","author":"Bein","year":"2017","journal-title":"Intensive Care Med"},{"key":"R66-20250729","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S2213-2600(21)00131-4","article-title":"Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?","volume":"9","author":"Supady","year":"2021","journal-title":"Lancet Respir Med"},{"key":"R67-20250729","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, healthcare workers, and health systems during the COVID-19 pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R68-20250729","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCULATIONAHA.120.047415","article-title":"Establishment and management of mechanical circulatory support during the COVID-19 Pandemic","volume":"142","author":"Pham","year":"2020","journal-title":"Circulation"},{"key":"R69-20250729","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S2213-2600(20)30316-7","article-title":"Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study","volume":"8","author":"Karagiannidis","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R70-20250729","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S2213-2600(20)30121-1","article-title":"Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases","volume":"8","author":"Ramanathan","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R71-20250729","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(20)32008-0","article-title":"Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry","volume":"396","author":"Barbaro","year":"2020","journal-title":"Lancet"},{"key":"R72-20250729","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13054-021-03634-1","article-title":"Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis","volume":"25","author":"Ramanathan","year":"2021","journal-title":"Crit Care"},{"key":"R73-20250729","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0140-6736(21)01960-7","article-title":"Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry","volume":"398","author":"Barbaro","year":"2021","journal-title":"Lancet"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:05:44Z","timestamp":1753819544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000956","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]}}}